Reproductive Health
16 articles on Reproductive Health, researched and written by the Shotlee Editorial Team from primary sources.
The 'life-changing' fertility effect for women on Mounjaro and Wegovy
Weight loss medications like Mounjaro and Wegovy are showing an unexpected 'life-changing' side effect for some women: an increase in fertility. This phenomenon, sometimes dubbed 'Ozempic babies,' is prompting important conversations about contraception and pregnancy planning.
8 min read
Study Links Hormonal Birth Control Use to Higher Likelihood of Needing Weight Loss Injections
A recent Danish study suggests that women who have used hormonal birth control may be more likely to seek weight loss injections such as Wegovy and Ozempic. This research sheds light on a long-reported, yet often unproven, connection between contraceptives and weight changes.
7 min read
GLP-1s for Teen Weight Loss: A New Treatment Trend?
GLP-1 medications are rapidly changing obesity care for teens and young adults, with a notable shift away from bariatric surgery. This article delves into the latest research, potential benefits, and important considerations for this emerging trend.
7 min read
Ozempic and Testosterone: Does Weight Loss Drive Sperm Quality Gains?
A comprehensive review of clinical trials suggests that GLP-1 medications may offer reproductive benefits for men with obesity-related low testosterone, potentially surpassing traditional hormone replacement therapies.
7 min read
Ozempic and Male Fertility: Can Semaglutide Boost Sperm Quality?
Emerging research indicates that GLP-1 medications, including Ozempic and Mounjaro, may offer unexpected benefits for male reproductive health by addressing underlying metabolic issues.
7 min read
Semaglutide and Male Fertility: New Study Reveals Testosterone Boost
Can GLP-1 medications like Ozempic or Wegovy improve male fertility? A new study indicates potential benefits for testosterone and sperm health, but what does this mean for patients?
7 min read
Semaglutide and Pregnancy: Understanding New Risks and Weight Rebound
A recent national database study reveals significant obstetric risks associated with semaglutide exposure before and during pregnancy, highlighting the importance of the weight rebound effect.
7 min read
Beyond BMI: Hidden Health Reasons Doctors May Decline Mounjaro or Wegovy
While BMI is a primary factor, a range of underlying health conditions and personal histories can lead to a doctor declining a prescription for popular weight loss medications like Mounjaro and Wegovy. Understanding these criteria is vital before seeking treatment.
7 min read
Ozempic, Wegovy & Mounjaro: AI Uncovers New Patient-Reported Side Effects
New research leverages AI to sift through vast online discussions, identifying patient-reported side effects of popular GLP-1 medications that may not be fully captured in clinical trials.
7 min read
Ozempic, Mounjaro & More: AI Uncovers Hidden GLP-1 Side Effects
Popular GLP-1 medications such as semaglutide and tirzepatide are revolutionizing weight loss and diabetes management. A groundbreaking study using AI to analyze over 400,000 Reddit posts has shed light on potential side effects that may not be fully captured in traditional clinical trials, offering valuable insights for patients and healthcare providers.
7 min read
PCOS Renamed PMOS: A New Era for Endocrine Health
Polycystic Ovary Syndrome (PCOS), a condition affecting millions of women, is undergoing a significant renaming to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change aims to better reflect the condition's complex interplay with endocrine and metabolic systems, potentially improving diagnosis and treatment.
8 min read
GLP-1 Drugs: Beyond Weight Loss – New Benefits and Risks Emerge
GLP-1 medications are revolutionizing weight management and diabetes care, but their impact extends far beyond the scale. This article delves into the emerging benefits and potential risks associated with these powerful drugs, offering a comprehensive overview for patients and healthcare providers.
8 min read
GLP-1s and Pregnancy: New Study Offers Cautious Reassurance
New research from the University of St Andrews offers a glimmer of hope for individuals using GLP-1 medications who become pregnant. This comprehensive review of nearly 50,000 pregnancies suggests a potentially lower risk of adverse outcomes than previously feared, though experts emphasize caution.
7 min read
Aston Gynaecologist Investigates Ozempic, Mounjaro Impact on PCOS
A leading gynaecologist at Aston Medical School is probing whether GLP-1 drugs like Ozempic and Mounjaro could transform care for women with PCOS. With a £60,000 NHS grant, Dr Shagaf Bakour aims to evaluate their effects on metabolic health and fertility. This investigation highlights hope for better treatment pathways amid rising interest in these weight loss jabs.
5 min read
In-Depth Analysis: Gonadorelin 5mg Research Peptide Use
Gonadorelin 5mg research peptide is gaining traction in studies of hormonal health and reproductive medicine. This synthetic GnRH mimic helps researchers investigate gonadotropin release, hormonal imbalances, and therapies for conditions like hypogonadism. Delve into its mechanisms, efficacy metrics, and essential ethical considerations for robust clinical research.
5 min read
GLP-1 Drugs: Weight Loss Benefits & Fertility Risks for Women
GLP-1 receptor agonists excel in weight management and glucose control, but their effects on women's reproductive health demand attention. These drugs can restore ovulation in obese women with insulin resistance, yet they risk unplanned pregnancies and are unsafe during gestation. Consult experts before use.
3 min read